BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:15 PM
 | 
Jul 31, 2007
 |  BC Extra  |  Top Story

Panel backs Tysabri for Crohn's

An FDA advisory panel on Tuesday agreed that Tysabri natalizumab from Elan (ELN) and Biogen Idec (BIIB) should be made available to patients with moderate to...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >